Grail has big plans for its blood cancer tests. The first step: Finding a new owner

In March, Paul Schneider was diagnosed with pancreatic cancer. The 77-year-old retired firefighter was grateful to receive the news.

He was symptom-free, and a blood test from the company Grail detected the often-incurable disease. After scans confirmed the diagnosis, he underwent chemotherapy that has kept the cancer at bay.

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks